ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665076 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665076; 2) Community: the network communities that were significantly associated with the response to NSC 665076; 3) Molecule: the relationships between components within communities and NSC 665076; 4) MDR: the compounds that were significantly associated with the NSC 665076.

NSC Compound Enrichment Correlation
NSC 683628 Null 0.000930692338491037 0.19038655
NSC 761817 (Z)-5-methoxy-3-((1-(3,4,5-trimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.000930692338491037 0.35773539
NSC 670813 Null 0.00115358042961468 0.84814611
NSC 710557 Null 0.00115358042961468 0.014480484
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.00115358042961469 0.50530733
NSC 660978 2-bromo-8-methoxy-6-methyl-1,4-naphthoquinone 0.00115358042961469 0.77329571
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0016365323975257 0.84597126
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.0016365323975257 0.62636661
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0016365323975257 0.78275245
NSC 668259 Null 0.00163653239752571 0.77254955
Total:91  Current:6    [First] [Prev] [Next] [Last]